Lumos Pharma Inc (LUMO)
4.30
-0.06
(-1.38%)
USD |
NASDAQ |
Nov 13, 16:00
4.30
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.0001 |
March 31, 2020 | 0.0002 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.0007 |
June 30, 2019 | 0.0007 |
March 31, 2019 | 0.0008 |
December 31, 2018 | 0.0009 |
September 30, 2018 | 0.0011 |
June 30, 2018 | 0.0013 |
Date | Value |
---|---|
March 31, 2018 | 0.0015 |
December 31, 2017 | 0.0018 |
September 30, 2017 | 0.0031 |
June 30, 2017 | 0.0038 |
March 31, 2017 | 0.004 |
December 31, 2016 | 0.004 |
September 30, 2016 | 0.0042 |
June 30, 2016 | 0.0043 |
March 31, 2016 | 0.0035 |
December 31, 2015 | 0.0048 |
September 30, 2015 | 0.0047 |
June 30, 2015 | 0.0045 |
March 31, 2015 | 0.0045 |
December 31, 2014 | 0.0056 |
September 30, 2014 | 0.0168 |
June 30, 2014 | 0.0155 |
March 31, 2014 | 0.0147 |
December 31, 2013 | 0.0204 |
September 30, 2013 | 0.0268 |
June 30, 2013 | 0.0242 |
March 31, 2013 | 0.0219 |
December 31, 2012 | 0.0719 |
September 30, 2012 | 0.3155 |
June 30, 2012 | 0.2442 |
March 31, 2012 | 0.2109 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0002
Maximum
Mar 2020
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Boston Scientific Corp | 0.5254 |
Calidi Biotherapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | -1.128 |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 21.36M |
Total Liabilities (Quarterly) | 11.08M |
Shareholders Equity (Quarterly) | 10.28M |
Current Ratio | 4.233 |